Skip to main content
The new Teacher Workspace is here. Your first 3 assignments are free. Try it →
A colleague sent you $30 off Fiveable. Get the annual plan for $99 →

Tardive Dyskinesia in AP Psychology

In AP Psychology, tardive dyskinesia is a side effect of long-term antipsychotic (neuroleptic) use. It causes involuntary, repetitive movements, especially in the lower face, and is tied to how the drugs disrupt dopamine regulation in the nervous system.

Verified for the 2027 AP Psychology exam•Last updated October 2026

What is Tardive Dyskinesia?

Tardive dyskinesia is a movement disorder that can show up after someone has taken antipsychotic drugs (also called neuroleptics) for a long time. The name tells you what it is. Tardive means "late" and dyskinesia means "abnormal movement." So it's a movement problem that arrives late, often after months or years of treatment. The movements are involuntary and repetitive, and they mostly hit the lower face. Think lip smacking, grimacing, or tongue movements the person can't control.

The CED describes it as "a movement disorder related to the regulation of dopamine in the nervous system" (AP Psych 5.5.F). Here's the logic. Antipsychotics treat symptoms of schizophrenia by blocking dopamine receptors. But dopamine doesn't only matter for thought and perception. It also helps control smooth, voluntary movement. Block it for long enough and the movement system can go haywire. Tardive dyskinesia is the price some patients pay for symptom relief.

Why Tardive Dyskinesia matters in AP® Psychology

Tardive dyskinesia lives in Unit 5: Mental and Physical Health, under Topic 5.5 Treatment of Psychological Disorders. It's named directly in the essential knowledge for AP Psych 5.5.F (interventions from the biological perspective) as the go-to example of a psychoactive medication side effect.

It matters because it's the clearest proof that biological treatments have real costs. That idea connects to AP Psych 5.5.B, since prescribing a drug that can cause lasting movement problems raises the ethical principle of nonmaleficence (do no harm). It also adds nuance to AP Psych 5.5.A. Antipsychotics helped drive deinstitutionalization in the late 20th century, and tardive dyskinesia reminds you those same drugs weren't side-effect free. If an exam question asks for a limitation of drug therapy, this is your strongest specific example.

How Tardive Dyskinesia connects across the course

Antipsychotic Medications and Dopamine Blocking (Unit 5)

Tardive dyskinesia only makes sense once you know what antipsychotics do. They block dopamine receptors to quiet symptoms like hallucinations and delusions. The side effect is basically the drug doing its job in the wrong part of the brain, where dopamine is busy running movement instead of thought.

Parkinson's Disease and Dopamine's Role in Movement (Unit 1)

Parkinson's disease shows what happens when dopamine-producing neurons die off. Movement gets shaky and hard to start. That's why it's no surprise that drugs that interfere with dopamine can also mess with movement. Same neurotransmitter, two different ways of disrupting it.

Ethical Principles in Treatment (Unit 5)

The APA principle of nonmaleficence means avoiding harm. Tardive dyskinesia turns that abstract principle into a real dilemma. A doctor has to weigh relief from psychosis against the risk of a lasting movement disorder, and the patient deserves to know that tradeoff.

Deinstitutionalization and the Rise of Drug Therapy (Unit 5)

Antipsychotics made it possible to release huge numbers of people from hospitals in the late 20th century. Tardive dyskinesia is the flip side of that success story. The drugs that made community treatment possible also left some long-term patients with visible side effects.

Is Tardive Dyskinesia on the AP® Psychology exam?

On the AP exam, tardive dyskinesia almost always appears in multiple-choice scenarios. Expect a stem like this: a patient with schizophrenia takes a drug that blocks dopamine receptors, and months later develops involuntary facial movements. You identify the side effect. Some questions flip it around and ask what the side effect demonstrates. The answer is a limitation of psychopharmacological (biological) treatment. Others ask why newer antipsychotics advertise fewer movement-related (extrapyramidal) side effects. The idea there is that newer drugs block dopamine less intensely or act on other neurotransmitters too.

No released FRQ has used the term verbatim. Still, it's a strong concrete example when an FRQ asks you to evaluate a biological treatment or apply an ethical principle like nonmaleficence. Your job is to name it, link it to long-term antipsychotic use and dopamine, and explain what it shows about the costs of drug therapy.

Tardive Dyskinesia vs Parkinson's Disease

Both involve movement problems and dopamine, which is why they get mixed up. Parkinson's disease is a neurological disorder in which dopamine-producing neurons die. It typically causes tremors, stiffness, and slowed movement. Tardive dyskinesia is a side effect of medication, specifically long-term antipsychotic use. It causes extra, involuntary movements, usually in the face. Here's a quick way to remember it. Parkinson's is something the brain does to itself, and tardive dyskinesia is something the drug does to the brain.

Key things to remember about Tardive Dyskinesia

  • Tardive dyskinesia is a movement disorder caused by long-term use of antipsychotic (neuroleptic) medications.

  • Its main symptom is involuntary, repetitive movement, especially in the lower face, like lip smacking or tongue movements.

  • It's tied to dopamine because antipsychotics block dopamine receptors, and dopamine also helps regulate movement.

  • The word tardive means late, which reminds you this side effect shows up after months or years of treatment, not right away.

  • On the exam, tardive dyskinesia is the go-to example of a limitation or cost of biological, drug-based treatment.

  • It connects to the ethical principle of nonmaleficence because doctors must weigh symptom relief against the risk of lasting harm.

Frequently asked questions about Tardive Dyskinesia

What is tardive dyskinesia in AP Psychology?

Tardive dyskinesia is a side effect of long-term antipsychotic use that causes involuntary movements, mostly in the lower face. The CED (AP Psych 5.5.F) describes it as a movement disorder related to dopamine regulation in the nervous system.

Is tardive dyskinesia caused by schizophrenia itself?

No. Tardive dyskinesia is caused by the medication used to treat schizophrenia, not the disorder. It develops after long-term use of antipsychotics that block dopamine receptors.

How is tardive dyskinesia different from Parkinson's disease?

Parkinson's disease happens when dopamine-producing neurons die, causing tremors and slowed movement. Tardive dyskinesia is a drug side effect that causes extra, involuntary movements, usually in the face. Both involve dopamine, but only tardive dyskinesia comes from medication.

Which drugs cause tardive dyskinesia?

Antipsychotic drugs, also called neuroleptics, cause tardive dyskinesia, especially when taken for a long time. Older antipsychotics carry a higher risk. Newer ones are designed to reduce movement-related side effects.

Is tardive dyskinesia on the AP Psych exam?

Yes. It's named directly in the essential knowledge for Topic 5.5 (AP Psych 5.5.F), so it can show up in multiple-choice questions. Those questions usually ask you to identify it from a scenario or explain what it shows about the limits of drug therapy.